Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay

Author： Glick Henry A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.4, 2011-04, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sample Size and Power for Cost-Effectiveness Analysis (Part 1)

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 189-198

Adis International

Access to resources Recommend Favorite

Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis

By Walter S.D.   Gafni Amiram   Birch Stephen  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 455-466

Adis International

Access to resources Recommend Favorite

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.  

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters

By Hoch Jeffrey S.   Dewa Carolyn S.  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 807-816

Adis International

Access to resources Recommend Favorite